You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 19, 2024

Details for New Drug Application (NDA): 205422

✉ Email this page to a colleague

« Back to Dashboard

NDA 205422 describes REXULTI, which is a drug marketed by Otsuka and is included in one NDA. It is available from two suppliers. There are six patents protecting this drug. Additional details are available on the REXULTI profile page.

The generic ingredient in REXULTI is brexpiprazole. There are eight drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the brexpiprazole profile page.
Summary for 205422
Pharmacology for NDA: 205422
Suppliers and Packaging for NDA: 205422
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
REXULTI brexpiprazole TABLET;ORAL 205422 NDA Otsuka America Pharmaceutical, Inc. 59148-035 59148-035-13 1 BOTTLE in 1 CARTON (59148-035-13) / 30 TABLET in 1 BOTTLE
REXULTI brexpiprazole TABLET;ORAL 205422 NDA Otsuka America Pharmaceutical, Inc. 59148-036 59148-036-07 1 BLISTER PACK in 1 CARTON (59148-036-07) / 7 TABLET in 1 BLISTER PACK

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength0.25MG
Approval Date:Jul 10, 2015TE:ABRLD:Yes
Regulatory Exclusivity Expiration:Dec 27, 2024
Regulatory Exclusivity Use:NEW PATIENT POPULATION
Regulatory Exclusivity Expiration:May 10, 2026
Patent:⤷  Sign UpPatent Expiration:Oct 12, 2032Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.